
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 29, 2024, titled "Glenmark Pharmaceuticals receives ANDA approval forAcetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC)".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 29, 2024, titled "Glenmark Pharmaceuticals receives ANDA approval forAcetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC)".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals